Skip to main content
European Commission logo print header

DELIVERy of advanced therapies for diabetes training network

Descrizione del progetto

Innovative terapie cellulari per il diabete

Il diabete è una malattia cronica che colpisce milioni di persone in tutto il mondo, alle quali devono essere somministrate iniezioni di insulina per tutta la vita. Il trapianto di isole pancreatiche è una terapia alternativa molto promettente che può ripristinare la produzione naturale di insulina e migliorare i sintomi del diabete. Tuttavia, le sfide associate richiedono che molti aspetti della terapia del trapianto per il diabete siano rivisti e ottimizzati. La missione del progetto DELIVER, finanziato dall’UE, è quella di formare giovani ricercatori per promuovere queste terapie cellulari. L’attenzione si concentra sul trapianto intramuscolare di isole pancreatiche e sulle strategie per prevenirne il rigetto. Il risultato del progetto mostra grandi potenzialità per migliorare la qualità di vita delle persone affette da diabete in tutto il mondo.

Obiettivo

The DELIVER EID programme aims to equip 6 industrial PhD graduates with all of the tools required to become creative, entrepreneurial and innovative leaders in the emerging European advanced therapies sector. Advanced therapies are new medicinal products based on genes or cells and tissue engineering products (biomaterials), sometimes used in combination with medical devices. They herald revolutionary treatments for a number of chronic diseases including Alzheimer’s, cancer and the focus of the DELIVER programme, Diabetes Mellitus. We aim to DELIVER the next cohort of translational research scientists in the field of advanced therapies and enabling medical devices for pancreatic islet transplantation, a cell therapy which is poised to become more widespread for the treatment of insulin-dependent diabetes. The DELIVER doctoral training network therefore represents a major interdisciplinary effort between cell biologists, experts in biomaterials, medical devices and advanced drug delivery, clinical experts in islet transplantation and research-active biotech and biomedical companies. Each DELIVER early stage researcher (ESR) will tailor a Personal Career Development Plan (PCDP) to ensure that over the course of the programme the core research skills, advanced research skills and intersectoral transferable skills for a successful career in the advanced therapies sector are acquired. Intersectoral transferable skills training will focus on enhancing career opportunities and employability of the trainees by developing their innovative and entrepreneurial capacity, their communication and leadership skills and their commercial awareness. This will result in graduates with all the skills necessary to innovate, develop and translate advanced therapies for diabetes for the benefit of European patients and industry.

Coordinatore

UNIVERSITY OF GALWAY
Contribution nette de l'UE
€ 549 368,64
Indirizzo
UNIVERSITY ROAD
H91 Galway
Irlanda

Mostra sulla mappa

Regione
Ireland Northern and Western West
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 549 368,64

Partecipanti (3)

Partner (3)